Swart I, Rossouw J, Loots JM, and et al
The practical difference that matters most today, though, is regulatory: tirzepatide is an approved medicine you can be prescribed, while retatrutide is still an investigational compound being evaluated in clinical trials
Call your health care provider immediately if you are experiencing any signs of an allergic reaction: skin rash, itching or hives, swelling of the face, lips, or tongue, blue tint to skin, chest tightness, pain, difficulty breathing, wheezing, dizziness, red, a swollen painful area/areas on the leg
( , , ) 9
Table 12 Results at week 26 in a trial comparing Liraglutide Injection in combination with metformin with or without basal insulin versus Placebo in combination with metformin with or without basal insulin in Pediatric Patients Aged 10 Years and Older with Type 2 Diabetes Mellitus 16.1 How Supplied Liraglutide Injection: 18 mg/3 mL (6 mg/mL) clear, colorless solution in a pre-filled, single-patient-use pen that delivers doses of 0.6 mg, 1.2 mg, or 1.8 mg is available in the following package sizes: 2 x Liraglutide Injection pen NDC 0143-9144-02 3 x Liraglutide Injection pen NDC 0143-9144-03 16.2 Recommended Storage Prior to first use, Liraglutide Injection should be stored in a refrigerator between 36F to 46F (2C to 8C)